BPC-157 and TB-500 are sold together so often that a lot of people assume they are one thing. They are two different peptides with two different origins, studied for overlapping reasons through quite different routes. Knowing which is which makes it much easier to read anything written about either.
The short version
- BPC-157 is a 15 amino acid sequence derived from a protein found in gastric juice. Its research is mostly about blood vessel growth, growth factor signalling and the nitric oxide system.
- TB-500 is a synthetic fragment of thymosin beta-4, a protein whose main documented job is binding actin. Its research is mostly about cell movement and tissue remodelling.
- Neither is approved as a medicine anywhere, and both are on the WADA prohibited list.
BPC-157 vs TB-500 in 60 seconds
- They are two different peptides, not one product with two names.
- BPC-157 comes from a gastric juice protein. Research focus: blood vessels, growth factors and nitric oxide.
- TB-500 is a fragment of thymosin beta-4. Research focus: cell movement and tissue remodelling.
- Almost all the evidence is from animals. Neither is an approved medicine and both are WADA prohibited.
BPC-157
The name stands for body protection compound. The sequence was identified in work on a protective protein in human gastric juice, which is why a large share of its literature is about the gut: ulcers, inflammation and the intestinal lining.
The rest of the research is about injury models in animals, mainly tendon, ligament, muscle and bone. The mechanisms most often proposed are angiogenesis (new blood vessel formation), increased expression of growth factor receptors in injured tissue, and effects on the nitric oxide system.
What is missing is human data. A 2025 systematic review of BPC-157 in orthopaedic sports medicine found 36 studies, 35 of them preclinical. The one clinical study was a retrospective report in which 7 of 12 people with chronic knee pain reported relief lasting more than six months. There are no large controlled human trials, and anyone describing BPC-157 as proven is describing a rat.

TB-500
Thymosin beta-4 is a small protein present in most cells. Its best understood role is holding on to actin, the structural protein cells use to change shape and move. A cell that needs to migrate into a damaged area needs actin to be available when and where it is wanted, and thymosin beta-4 is part of how that is managed.
TB-500 is a synthetic fragment built around the actin-binding region of that protein. Research on thymosin beta-4 covers wound healing, cardiac tissue and eye injury models. Research on the TB-500 fragment itself is thinner still, and most of what is said about it is borrowed from work on the full protein.

BPC-157
- Origin: a protective protein in gastric juice
- 15 amino acids
- Studied for: gut, tendon, ligament, muscle and bone in animals
- Proposed route: blood supply, growth factors, nitric oxide
TB-500
- Origin: a fragment of thymosin beta-4
- Binds actin, which cells use to move
- Studied for: wound healing, cardiac and eye injury models
- Proposed route: getting cells into place
Why they get stacked
The argument for running them together is that they approach the same problem from different directions. BPC-157 is largely a signalling story: blood supply and growth factors. TB-500 is largely a structural one: getting cells to move into place. Two routes towards the same endpoint is the whole case for the combination, and it is why most published repair protocols in animals use both.
It is a reasonable hypothesis. It is not a result. There is no controlled human trial of the combination.
How to read what people say about them
Three questions sort most of it out.
- Was it a person or an animal? Most of the striking results for both compounds come from animal injury models. That is where repair research starts, and it is why these two are among the most studied compounds in the field.
- Which compound was actually studied? A lot of what is written about TB-500 is really about the full thymosin beta-4 protein. They are related, not identical.
- Who made the vial? Purity varies between manufacturers in this market. A supplier who can show you a certificate of analysis for the batch is worth more than one with a better story.
If you compete
Both are prohibited by the World Anti-Doping Agency at all times, in and out of competition. BPC-157 falls under non-approved substances. Thymosin beta-4 and its fragments, which includes TB-500, fall under growth factors. If you are tested, the answer is no.
What we stock
We do not sell TB-500 on its own. It comes combined with BPC-157 in the Wolverine Stack 10mg and Wolverine Stack 20mg vials, and in the Wolverine 10mg Pen. BPC-157 on its own is available as the BPC-157 10mg Pen. The Deadpool Stack is a broader repair blend; ask us for its exact composition before ordering if it matters to you.
Everything here is supplied for research use only. It is not a registered medicine.
Questions people ask
Is BPC-157 the same as TB-500?
No. BPC-157 is a 15 amino acid sequence derived from a gastric juice protein. TB-500 is a synthetic fragment of thymosin beta-4.
Is there human evidence for BPC-157?
Very little. A 2025 systematic review found 36 studies, 35 of them preclinical. The one clinical study was a retrospective report, and there are no large controlled human trials.
Are BPC-157 and TB-500 banned in sport?
Yes. Both are on the World Anti-Doping Agency prohibited list at all times. If you are tested, the answer is no.
Do you sell TB-500 on its own?
No. It comes combined with BPC-157 in the Wolverine Stack vials and pen. BPC-157 on its own is available as a pen.
Sources
- Vasireddi N, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J 2025;21(4):485-495.
- US Anti-Doping Agency. BPC-157: experimental peptide creates risk for athletes.
- World Anti-Doping Agency. The Prohibited List (check the current year for exact wording).
Browsing by goal? See peptides for joints and tendons and peptides for recovery and injury.
Vial buyers: our reconstitution guide covers the preparation, and how to store peptides covers what happens after. The full range is in recovery and repair.

